Advisory Board

Steven D. Averbuch, M.D.

• Vice President | Translational Clinical Development and Pharmacodiagnostics for Bristol-Myers Squibb Company


Anand C. Burman, Ph.D.

• Vice Chairman | Dabur India
• Chairman | Dabur Pharma Limited


John Fisher, M.D.

• Partner | Radiology Associates of Clearwater
• Chief Executive Officer | Biopsy Sciences


Lesa Mitchell (ex-officio)

• Vice President, Advancing Medical Innovation | Ewing Marion Kauffman Foundation


Lili M. Portilla, MPA

• Acting Director of Policy, Communications and Strategic Alliances | National Center for Advancing Translational Sciences (NCATS), NIH
• Board Member (ex-officio) | University Industry Demonstration Project of the National Archives


Michael Powell, Ph.D.

• General Partner | Sofinnova Ventures
• Board President | AIDS Vaccine Advocacy Coalition


Michael D. Webb

• President and Chief Executive Officer | Allegro Diagnostics
• Chairman of the Board | Virtify


Joy Wheeler

• President | Leadership Solutions, Healthcare Administration Consultant
• Board member | Kansas University Medical Center, Advancement Board & School of Nursing Advisory Board, Foundation Board Chair - Truman Medical Center, University of Missouri - KC, Board Trustees and Executive Committee, Medical School Board Advisors


Thomas Wiggans

• Chief Executive Officer and Director | Dermira, Inc.
• Board member | Onyx Pharmaceuticals, Sangamo and Lithera


David Vranicar

• Board member | InvestMidwest and Kansas BIO

Last modified: Jan 28, 2014
IAMI Advisory Board duties

The IAMI Advisory Board is composed of nine national and international leaders in medical innovation. The board:

provides insight and advocates for the discovery and development of medical innovations

provides expertise in reviewing and selecting projects

assists in developing a network of potential partners

provides philanthropic development support to target individual, corporate and foundation contributions for the sustainability of IAMI

ID=x4304